Ingenuity and diversity driven by unmet market needs . . .
Enopace Biomedical is developing the only in the world intravascular neurostimulator, implanted percutaneously through a femoral approach. The device is designed to treat Congestive Heart Failure patients by reducing the left ventricle workload, increasing Aortic compliance and balancing the Autonomic Nervous System.
Maxillent is developing and commercializing an innovative, minimally invasive, technique for dental sinus lift procedures. The device and technique reduces the need for complex surgery required for about 25% of dental implant procedures, minimizing pain and complications.
GluSense is developing an injectable long-term Continuous Glucose Monitor (CGM) to improve accuracy and comfort of Glucose management by people with Diabetes.
Perifect is developing an innovative video guided Pericardial Access device. The device simplifies pericardial access and makes it safer, opening the door to multiple emerging procedures such as epicardial ablation, epicardial pacing, left-atrial appendage closure and more.
Nano-Retina is developing a miniature Artificial Retina to restore vision for people blind due to retinal degeneration. The advanced miniature device is implanted in a minimally invasive technique under local anesthesia and provides superior vision resolution due to its 600 proprietary electrodes and 3DNi™ technology.
ChroniSense Medical develops wearable medical-grade devices that monitor vital signs and other health factors, allowing patients and healthcare professionals to manage chronic disease without interfering with the patient’s everyday activity – in or outside the home.
Vascular Dynamics is developing an implantable stent-like device to treat resistive hypertension. The simple device is placed in the carotid artery in a percutaneous femoral approach procedure, and has been shown in clinical studies to reduce blood pressure in patients with drug resistant hypertension.
BlueWind Medical is developing a novel wireless neuro-stimulation platform for the treatment of various clinical indications. Its first products are approved in Europe for treating Peripheral Neuropathic Pain (PNP) and Over Active Bladder (OAB).
Slender Medical is developing a novel skin rejuvenation home treatment using non-invasive high intensity focused ultrasound (HIFU).
Roboscopy Medical develops an efficient, low cost robotic system for minimally-invasive surgical procedures.
Pythagoras Medical is developing a novel mapping system to guide renal denervation procedures, identifying appropriate denervation locations and providing immediate feedback on the success of the denervation process.